Annual Total Long Term Liabilities
$25.84 M
+$14.91 M+136.49%
31 December 2023
Summary:
Akero Therapeutics annual total long term liabilities is currently $25.84 million, with the most recent change of +$14.91 million (+136.49%) on 31 December 2023. During the last 3 years, it has risen by +$24.32 million (+1604.29%). AKRO annual total long term liabilities is now -79.29% below its all-time high of $124.73 million, reached on 31 December 2018.AKRO Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$35.93 M
+$129.00 K+0.36%
30 September 2024
Summary:
Akero Therapeutics quarterly total long term liabilities is currently $35.93 million, with the most recent change of +$129.00 thousand (+0.36%) on 30 September 2024. Over the past year, it has increased by +$12.18 million (+51.29%). AKRO quarterly long term liabilities is now -71.19% below its all-time high of $124.73 million, reached on 31 December 2018.AKRO Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AKRO Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +136.5% | +51.3% |
| 3 y3 years | +1604.3% | +2532.3% |
| 5 y5 years | -79.3% | +10000.0% |
AKRO Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1870.8% | at high | +2763.0% |
| 5 y | 5 years | -79.3% | >+9999.0% | at high | >+9999.0% |
| alltime | all time | -79.3% | >+9999.0% | -71.2% |
Akero Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $35.93 M(+0.4%) |
| June 2024 | - | $35.80 M(+0.2%) |
| Mar 2024 | - | $35.73 M(+38.3%) |
| Dec 2023 | $25.84 M(+136.5%) | $25.84 M(+8.8%) |
| Sept 2023 | - | $23.75 M(-7.8%) |
| June 2023 | - | $25.77 M(-0.1%) |
| Mar 2023 | - | $25.80 M(+136.1%) |
| Dec 2022 | $10.93 M(+733.3%) | $10.93 M(+2.5%) |
| Sept 2022 | - | $10.66 M(+0.5%) |
| June 2022 | - | $10.61 M(+745.1%) |
| Mar 2022 | - | $1.25 M(-4.3%) |
| Dec 2021 | $1.31 M | $1.31 M(-4.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $1.36 M(-3.7%) |
| June 2021 | - | $1.42 M(-3.4%) |
| Mar 2021 | - | $1.47 M(-3.2%) |
| Dec 2020 | $1.52 M(+6491.3%) | $1.52 M(-3.1%) |
| Sept 2020 | - | $1.56 M(>+9900.0%) |
| June 2020 | - | $2000.00(-83.3%) |
| Mar 2020 | - | $12.00 K(-47.8%) |
| Dec 2019 | $23.00 K(-100.0%) | $23.00 K(-32.4%) |
| Sept 2019 | - | $34.00 K(-12.8%) |
| June 2019 | - | $39.00 K(>+9900.0%) |
| Mar 2019 | - | $0.00(-100.0%) |
| Dec 2018 | $124.73 M(+2394.6%) | $124.73 M |
| Dec 2017 | $5.00 M | - |
FAQ
- What is Akero Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Akero Therapeutics?
- What is Akero Therapeutics annual total long term liabilities year-on-year change?
- What is Akero Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Akero Therapeutics?
- What is Akero Therapeutics quarterly long term liabilities year-on-year change?
What is Akero Therapeutics annual total long term liabilities?
The current annual total long term liabilities of AKRO is $25.84 M
What is the all time high annual total long term liabilities for Akero Therapeutics?
Akero Therapeutics all-time high annual total long term liabilities is $124.73 M
What is Akero Therapeutics annual total long term liabilities year-on-year change?
Over the past year, AKRO annual total long term liabilities has changed by +$14.91 M (+136.49%)
What is Akero Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of AKRO is $35.93 M
What is the all time high quarterly long term liabilities for Akero Therapeutics?
Akero Therapeutics all-time high quarterly total long term liabilities is $124.73 M
What is Akero Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, AKRO quarterly total long term liabilities has changed by +$12.18 M (+51.29%)